Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

SELF-TEST FOR GLUCOSE - ANVISA Registration 81414021715

Access comprehensive regulatory information for SELF-TEST FOR GLUCOSE in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81414021715 and manufactured by ROCHE DIABETES CARE GMBH. The registration is held by ROCHE DIABETES CARE BRASIL LTDA with validity until Sep 23, 2034.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including OK BIOTECH CO., LTD., ROCHE DIABETES CARE GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
81414021715
2 Related Devices
Registration Details
ANVISA Registration Number: 81414021715
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

CareTech Tiras
Risk Class III

Registration Details

81414021715

25351156063202446

23552212000187

Company Information

Germany
PT: ALEMANHA

Dates and Status

Sep 23, 2024

23/09/2034

09/18/2025 19:00:01

CareTech Tiras
Risk Class III

Registration Details

81414021715

25351156063202446

23552212000187

Company Information

Dates and Status

Sep 23, 2024

23/09/2034

09/18/2025 19:00:01